Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Jade Biosciences, Inc. (JBIO) since 2021 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Jade Biosciences, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1798749.
Total stock buying since 2021: $72,594,307.
Total stock sales since 2021: $17,358,778.
Total stock option exercises since 2021: $2,191,561.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 6,000 | $44,400 | 0 | $0 | 0 | $0 |
| 2024 | 928,110 | $1,549,943 | 257,325 | $6,562,808 | 255,066 | $1,095,994 |
| 2023 | 0 | $0 | 262,343 | $5,093,848 | 262,829 | $521,878 |
| 2022 | 0 | $0 | 281,230 | $5,702,122 | 285,788 | $573,689 |
| 2021 | 5,071,426 | $70,999,964 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-05 | 6,000 | $44,400 | 0 | $0 | 0 | $0 |
| 2024-08 | 0 | $0 | 0 | $0 | 1,507 | $2,622 |
| 2024-07 | 0 | $0 | 0 | $0 | 11,454 | $19,929 |
| 2024-06 | 928,110 | $1,549,943 | 31,600 | $787,450 | 31,600 | $199,594 |
| 2024-05 | 0 | $0 | 27,338 | $576,088 | 24,000 | $51,360 |
| 2024-04 | 0 | $0 | 71,355 | $1,991,940 | 59,473 | $219,819 |
| 2024-03 | 0 | $0 | 109,832 | $2,880,181 | 109,832 | $570,903 |
| 2024-02 | 0 | $0 | 8,600 | $161,188 | 8,600 | $15,883 |
| 2024-01 | 0 | $0 | 8,600 | $165,961 | 8,600 | $15,884 |
| 2023-12 | 0 | $0 | 31,008 | $555,682 | 35,008 | $63,939 |
| 2023-11 | 0 | $0 | 42,751 | $653,472 | 40,689 | $79,933 |
| 2023-09 | 0 | $0 | 3,961 | $59,635 | 3,961 | $7,690 |
| 2023-08 | 0 | $0 | 10,283 | $163,108 | 10,283 | $19,949 |
| 2023-07 | 0 | $0 | 32,533 | $571,273 | 32,533 | $67,113 |
| 2023-06 | 0 | $0 | 12,533 | $207,551 | 12,533 | $24,314 |
| 2023-05 | 0 | $0 | 30,141 | $637,978 | 28,689 | $58,424 |
| 2023-04 | 0 | $0 | 31,533 | $598,421 | 31,533 | $63,374 |
| 2023-03 | 0 | $0 | 27,532 | $665,853 | 27,532 | $56,412 |
| 2023-02 | 0 | $0 | 27,534 | $651,136 | 27,534 | $56,415 |
| 2023-01 | 0 | $0 | 12,534 | $329,739 | 12,534 | $24,315 |
| 2022-12 | 0 | $0 | 169,188 | $3,333,554 | 169,188 | $354,060 |
| 2022-11 | 0 | $0 | 23,460 | $447,558 | 23,460 | $50,198 |
| 2022-10 | 0 | $0 | 17,204 | $327,019 | 17,204 | $36,364 |
| 2022-09 | 0 | $0 | 20,668 | $382,234 | 25,226 | $44,834 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-05-16 | Frohlich Tom (Chief Executive Officer) | Buy | 6,000 | 7.40 | 44,400 |
| 2024-08-01 | Dake Benjamin T (SEE REMARKS) | Option Ex | 1,507 | 1.74 | 2,622 |
| 2024-07-31 | Dake Benjamin T (SEE REMARKS) | Option Ex | 11,454 | 1.74 | 19,929 |
| 2024-06-17 | Shah Rajeev M. | Buy | 928,110 | 1.67 | 1,549,943 |
| 2024-06-14 | Verwijs Marinus (CHIEF TECHNICAL OFFICER) | Sale | 10,600 | 25.00 | 265,000 |
| 2024-06-14 | Verwijs Marinus (CHIEF TECHNICAL OFFICER) | Option Ex | 10,600 | 14.59 | 154,654 |
| 2024-06-14 | Eldridge George A (SEE REMARKS) | Sale | 15,000 | 25.03 | 375,450 |
| 2024-06-14 | Eldridge George A (SEE REMARKS) | Option Ex | 15,000 | 2.14 | 32,100 |
| 2024-06-13 | Gillies Hunter (CHIEF MEDICAL OFFICER) | Sale | 6,000 | 24.50 | 147,000 |
| 2024-06-13 | Gillies Hunter (CHIEF MEDICAL OFFICER) | Option Ex | 6,000 | 2.14 | 12,840 |
| 2024-05-17 | Gillies Hunter (CHIEF MEDICAL OFFICER) | Sale | 4,000 | 21.46 | 85,852 |
| 2024-05-17 | Gillies Hunter (CHIEF MEDICAL OFFICER) | Option Ex | 4,000 | 2.14 | 8,560 |
| 2024-05-16 | Noyes Timothy P (CHIEF EXECUTIVE OFFICER) | Sale | 10,000 | 21.72 | 217,230 |
| 2024-05-16 | Noyes Timothy P (CHIEF EXECUTIVE OFFICER) | Option Ex | 10,000 | 2.14 | 21,400 |
| 2024-05-02 | Verwijs Marinus (CHIEF TECHNICAL OFFICER) | Sale | 1,981 | 21.02 | 41,630 |
| 2024-05-01 | Noyes Timothy P (CHIEF EXECUTIVE OFFICER) | Sale | 11,357 | 20.37 | 231,376 |
| 2024-05-01 | Noyes Timothy P (CHIEF EXECUTIVE OFFICER) | Option Ex | 10,000 | 2.14 | 21,400 |
| 2024-04-17 | Dake Benjamin T (SEE REMARKS) | Sale | 6,853 | 23.15 | 158,660 |
| 2024-04-17 | Dake Benjamin T (SEE REMARKS) | Option Ex | 6,853 | 2.14 | 14,665 |
| 2024-04-17 | Gillies Hunter (CHIEF MEDICAL OFFICER) | Sale | 4,000 | 22.81 | 91,256 |
| 2024-04-17 | Gillies Hunter (CHIEF MEDICAL OFFICER) | Option Ex | 4,000 | 1.74 | 6,960 |
| 2024-04-16 | Noyes Timothy P (CHIEF EXECUTIVE OFFICER) | Sale | 10,000 | 24.67 | 246,690 |
| 2024-04-16 | Noyes Timothy P (CHIEF EXECUTIVE OFFICER) | Option Ex | 10,000 | 2.14 | 21,400 |
| 2024-04-10 | Eldridge George A (SEE REMARKS) | Sale | 7,500 | 27.17 | 203,760 |
| 2024-04-10 | Eldridge George A (SEE REMARKS) | Option Ex | 7,500 | 2.14 | 16,050 |
| 2024-04-09 | Grayzel David S. | Sale | 11,882 | 28.15 | 334,478 |
| 2024-04-01 | Verwijs Marinus (CHIEF TECHNICAL OFFICER) | Sale | 5,300 | 29.43 | 155,994 |
| 2024-04-01 | Verwijs Marinus (CHIEF TECHNICAL OFFICER) | Option Ex | 5,300 | 14.59 | 77,327 |
| 2024-04-01 | Dake Benjamin T (SEE REMARKS) | Sale | 3,325 | 31.98 | 106,316 |
| 2024-04-01 | Dake Benjamin T (SEE REMARKS) | Option Ex | 3,325 | 10.61 | 35,278 |
| 2024-04-01 | Eldridge George A (SEE REMARKS) | Sale | 12,495 | 31.23 | 390,206 |
| 2024-04-01 | Eldridge George A (SEE REMARKS) | Option Ex | 12,495 | 2.14 | 26,739 |
| 2024-04-01 | Noyes Timothy P (CHIEF EXECUTIVE OFFICER) | Sale | 10,000 | 30.46 | 304,580 |
| 2024-04-01 | Noyes Timothy P (CHIEF EXECUTIVE OFFICER) | Option Ex | 10,000 | 2.14 | 21,400 |
| 2024-03-28 | Gillies Hunter (CHIEF MEDICAL OFFICER) | Sale | 9,000 | 29.50 | 265,500 |
| 2024-03-28 | Gillies Hunter (CHIEF MEDICAL OFFICER) | Option Ex | 9,000 | 2.14 | 19,260 |
| 2024-03-27 | Dake Benjamin T (SEE REMARKS) | Sale | 11,068 | 27.96 | 309,516 |
| 2024-03-27 | Dake Benjamin T (SEE REMARKS) | Option Ex | 11,068 | 10.61 | 117,431 |
| 2024-03-25 | Dake Benjamin T (SEE REMARKS) | Sale | 3,432 | 28.01 | 96,120 |
| 2024-03-25 | Dake Benjamin T (SEE REMARKS) | Option Ex | 3,432 | 10.61 | 36,413 |
| 2024-03-19 | Verwijs Marinus (CHIEF TECHNICAL OFFICER) | Sale | 5,300 | 26.07 | 138,155 |
| 2024-03-19 | Verwijs Marinus (CHIEF TECHNICAL OFFICER) | Option Ex | 5,300 | 14.59 | 77,327 |
| 2024-03-18 | Dake Benjamin T (SEE REMARKS) | Sale | 35,057 | 26.11 | 915,408 |
| 2024-03-18 | Dake Benjamin T (SEE REMARKS) | Option Ex | 35,057 | 6.38 | 223,488 |
| 2024-03-18 | Gillies Hunter (CHIEF MEDICAL OFFICER) | Sale | 7,000 | 26.11 | 182,756 |
| 2024-03-18 | Gillies Hunter (CHIEF MEDICAL OFFICER) | Option Ex | 7,000 | 1.94 | 13,580 |
| 2024-03-13 | Eldridge George A (SEE REMARKS) | Sale | 2,016 | 25.02 | 50,444 |
| 2024-03-13 | Eldridge George A (SEE REMARKS) | Option Ex | 2,016 | 2.14 | 4,314 |
| 2024-03-12 | Eldridge George A (SEE REMARKS) | Sale | 2,051 | 25.05 | 51,369 |
| 2024-03-12 | Eldridge George A (SEE REMARKS) | Option Ex | 2,051 | 2.14 | 4,389 |
| 2024-03-11 | Eldridge George A (SEE REMARKS) | Sale | 3,433 | 25.77 | 88,482 |
| 2024-03-11 | Eldridge George A (SEE REMARKS) | Option Ex | 3,433 | 2.14 | 7,346 |
| 2024-03-08 | Eldridge George A (SEE REMARKS) | Sale | 114 | 25.00 | 2,850 |
| 2024-03-08 | Eldridge George A (SEE REMARKS) | Option Ex | 114 | 2.14 | 243 |
| 2024-03-07 | Gillies Hunter (CHIEF MEDICAL OFFICER) | Sale | 8,975 | 24.50 | 219,887 |
| 2024-03-07 | Gillies Hunter (CHIEF MEDICAL OFFICER) | Option Ex | 8,975 | 2.14 | 19,206 |
| 2024-03-07 | Eldridge George A (SEE REMARKS) | Sale | 22,386 | 25.00 | 559,694 |
| 2024-03-07 | Eldridge George A (SEE REMARKS) | Option Ex | 22,386 | 2.14 | 47,906 |
| 2024-02-23 | Gillies Hunter (CHIEF MEDICAL OFFICER) | Sale | 511 | 19.50 | 9,964 |
| 2024-02-23 | Gillies Hunter (CHIEF MEDICAL OFFICER) | Option Ex | 511 | 1.74 | 889 |
| 2024-02-20 | Gillies Hunter (CHIEF MEDICAL OFFICER) | Sale | 3,489 | 20.34 | 70,973 |
| 2024-02-20 | Gillies Hunter (CHIEF MEDICAL OFFICER) | Option Ex | 3,489 | 1.74 | 6,070 |
| 2024-02-05 | Niven Ralph (CHIEF SCIENTIFIC OFFICER) | Sale | 4,600 | 17.45 | 80,251 |
| 2024-02-05 | Niven Ralph (CHIEF SCIENTIFIC OFFICER) | Option Ex | 4,600 | 1.94 | 8,924 |
| 2024-01-17 | Gillies Hunter (CHIEF MEDICAL OFFICER) | Sale | 4,000 | 19.50 | 78,000 |
| 2024-01-17 | Gillies Hunter (CHIEF MEDICAL OFFICER) | Option Ex | 4,000 | 1.74 | 6,960 |
| 2024-01-05 | Niven Ralph (CHIEF SCIENTIFIC OFFICER) | Sale | 4,600 | 19.12 | 87,961 |
| 2024-01-05 | Niven Ralph (CHIEF SCIENTIFIC OFFICER) | Option Ex | 4,600 | 1.94 | 8,924 |
| 2023-12-27 | Gillies Hunter (CHIEF MEDICAL OFFICER) | Sale | 125 | 24.50 | 3,062 |
| 2023-12-27 | Gillies Hunter (CHIEF MEDICAL OFFICER) | Option Ex | 125 | 2.14 | 267 |
| 2023-12-20 | Gillies Hunter (CHIEF MEDICAL OFFICER) | Sale | 4,000 | 19.50 | 78,000 |
| 2023-12-14 | Gillies Hunter (CHIEF MEDICAL OFFICER) | Sale | 9,897 | 19.50 | 192,991 |
| 2023-12-14 | Gillies Hunter (CHIEF MEDICAL OFFICER) | Option Ex | 9,897 | 1.74 | 17,220 |
| 2023-12-13 | Gillies Hunter (CHIEF MEDICAL OFFICER) | Sale | 2,103 | 19.50 | 41,008 |
| 2023-12-13 | Gillies Hunter (CHIEF MEDICAL OFFICER) | Option Ex | 6,103 | 1.74 | 10,619 |
| 2023-12-06 | Dake Benjamin T (SEE REMARKS) | Sale | 10,283 | 16.11 | 165,628 |
| 2023-12-06 | Dake Benjamin T (SEE REMARKS) | Option Ex | 10,283 | 1.94 | 19,949 |
| 2023-12-05 | Niven Ralph (CHIEF SCIENTIFIC OFFICER) | Sale | 4,600 | 16.30 | 74,993 |
| 2023-12-05 | Niven Ralph (CHIEF SCIENTIFIC OFFICER) | Option Ex | 4,600 | 1.94 | 8,924 |
| 2023-11-27 | Dake Benjamin T (SEE REMARKS) | Sale | 12,517 | 16.24 | 203,238 |
| 2023-11-27 | Dake Benjamin T (SEE REMARKS) | Option Ex | 12,517 | 1.94 | 24,282 |
| 2023-11-24 | Dake Benjamin T (SEE REMARKS) | Sale | 4,990 | 15.90 | 79,345 |
| 2023-11-24 | Dake Benjamin T (SEE REMARKS) | Option Ex | 4,990 | 2.14 | 10,678 |
| 2023-11-22 | Dake Benjamin T (SEE REMARKS) | Sale | 9,382 | 15.17 | 142,362 |
| 2023-11-22 | Dake Benjamin T (SEE REMARKS) | Option Ex | 9,382 | 1.94 | 18,201 |
| 2023-11-22 | Niven Ralph (CHIEF SCIENTIFIC OFFICER) | Sale | 13,800 | 15.00 | 207,000 |
| 2023-11-22 | Niven Ralph (CHIEF SCIENTIFIC OFFICER) | Option Ex | 13,800 | 1.94 | 26,772 |
| 2023-11-01 | Verwijs Marinus (CHIEF TECHNOLOGY OFFICER) | Sale | 970 | 10.46 | 10,149 |
| 2023-11-01 | Noyes Timothy P (CHIEF EXECUTIVE OFFICER) | Sale | 1,092 | 10.42 | 11,378 |
| 2023-09-07 | Dake Benjamin T (SEE REMARKS) | Sale | 30 | 15.01 | 450 |
| 2023-09-07 | Dake Benjamin T (SEE REMARKS) | Option Ex | 30 | 2.14 | 64 |
| 2023-09-06 | Dake Benjamin T (SEE REMARKS) | Sale | 3,931 | 15.06 | 59,185 |
| 2023-09-06 | Dake Benjamin T (SEE REMARKS) | Option Ex | 3,931 | 1.94 | 7,626 |
| 2023-08-07 | Dake Benjamin T (SEE REMARKS) | Sale | 10,283 | 15.86 | 163,108 |
| 2023-08-07 | Dake Benjamin T (SEE REMARKS) | Option Ex | 10,283 | 1.94 | 19,949 |
| 2023-07-28 | Noyes Timothy P (CHIEF EXECUTIVE OFFICER) | Sale | 5,478 | 18.00 | 98,604 |
| 2023-07-28 | Noyes Timothy P (CHIEF EXECUTIVE OFFICER) | Option Ex | 5,478 | 2.14 | 11,722 |
| 2023-07-17 | Noyes Timothy P (CHIEF EXECUTIVE OFFICER) | Sale | 4,522 | 18.11 | 81,897 |
| 2023-07-17 | Noyes Timothy P (CHIEF EXECUTIVE OFFICER) | Option Ex | 4,522 | 2.14 | 9,677 |
| 2023-07-06 | Dake Benjamin T (SEE REMARKS) | Sale | 10,283 | 16.66 | 171,283 |
| 2023-07-06 | Dake Benjamin T (SEE REMARKS) | Option Ex | 10,283 | 1.94 | 19,949 |
| 2023-07-05 | Niven Ralph (CHIEF SCIENTIFIC OFFICER) | Sale | 2,250 | 17.55 | 39,489 |
| 2023-07-05 | Niven Ralph (CHIEF SCIENTIFIC OFFICER) | Option Ex | 2,250 | 1.94 | 4,365 |
| 2023-07-03 | Noyes Timothy P (CHIEF EXECUTIVE OFFICER) | Sale | 10,000 | 18.00 | 180,000 |
| 2023-07-03 | Noyes Timothy P (CHIEF EXECUTIVE OFFICER) | Option Ex | 10,000 | 2.14 | 21,400 |
| 2023-06-06 | Dake Benjamin T (SEE REMARKS) | Sale | 10,283 | 16.63 | 170,975 |
| 2023-06-06 | Dake Benjamin T (SEE REMARKS) | Option Ex | 10,283 | 1.94 | 19,949 |
| 2023-06-05 | Niven Ralph (CHIEF SCIENTIFIC OFFICER) | Sale | 2,250 | 16.26 | 36,576 |
| 2023-06-05 | Niven Ralph (CHIEF SCIENTIFIC OFFICER) | Option Ex | 2,250 | 1.94 | 4,365 |
| 2023-05-19 | Gillies Hunter (CHIEF MEDICAL OFFICER) | Sale | 65 | 19.50 | 1,267 |
| 2023-05-19 | Gillies Hunter (CHIEF MEDICAL OFFICER) | Option Ex | 65 | 1.74 | 113 |
| 2023-05-17 | Gillies Hunter (CHIEF MEDICAL OFFICER) | Sale | 1,090 | 19.59 | 21,356 |
| 2023-05-17 | Gillies Hunter (CHIEF MEDICAL OFFICER) | Option Ex | 1,090 | 1.74 | 1,896 |
| 2023-05-08 | Dake Benjamin T (SEE REMARKS) | Sale | 10,284 | 22.18 | 228,099 |
| 2023-05-08 | Dake Benjamin T (SEE REMARKS) | Option Ex | 10,284 | 1.94 | 19,950 |
| 2023-05-05 | Niven Ralph (CHIEF SCIENTIFIC OFFICER) | Sale | 2,250 | 21.21 | 47,731 |
| 2023-05-05 | Niven Ralph (CHIEF SCIENTIFIC OFFICER) | Option Ex | 2,250 | 1.94 | 4,365 |
| 2023-05-03 | Verwijs Marinus (SENIOR VICE PRESIDENT, CMC) | Sale | 759 | 20.79 | 15,779 |
| 2023-05-02 | Noyes Timothy P (CHIEF EXECUTIVE OFFICER) | Sale | 693 | 21.15 | 14,656 |
| 2023-05-01 | Noyes Timothy P (CHIEF EXECUTIVE OFFICER) | Sale | 15,000 | 20.61 | 309,090 |
| 2023-05-01 | Noyes Timothy P (CHIEF EXECUTIVE OFFICER) | Option Ex | 15,000 | 2.14 | 32,100 |
| 2023-04-21 | Gillies Hunter (CHIEF MEDICAL OFFICER) | Sale | 4,000 | 19.50 | 78,000 |
| 2023-04-21 | Gillies Hunter (CHIEF MEDICAL OFFICER) | Option Ex | 4,000 | 1.74 | 6,960 |
| 2023-04-06 | Dake Benjamin T (SEE REMARKS) | Sale | 10,283 | 18.17 | 186,831 |
| 2023-04-06 | Dake Benjamin T (SEE REMARKS) | Option Ex | 10,283 | 1.94 | 19,949 |
| 2023-04-05 | Niven Ralph (CHIEF SCIENTIFIC OFFICER) | Sale | 2,250 | 18.51 | 41,645 |
| 2023-04-05 | Niven Ralph (CHIEF SCIENTIFIC OFFICER) | Option Ex | 2,250 | 1.94 | 4,365 |
| 2023-04-03 | Noyes Timothy P (CHIEF EXECUTIVE OFFICER) | Sale | 15,000 | 19.46 | 291,945 |
| 2023-04-03 | Noyes Timothy P (CHIEF EXECUTIVE OFFICER) | Option Ex | 15,000 | 2.14 | 32,100 |
| 2023-03-06 | Dake Benjamin T (SEE REMARKS) | Sale | 10,282 | 24.10 | 247,837 |
| 2023-03-06 | Dake Benjamin T (SEE REMARKS) | Option Ex | 10,282 | 1.94 | 19,947 |
| 2023-03-06 | Niven Ralph (CHIEF SCIENTIFIC OFFICER) | Sale | 2,250 | 24.32 | 54,731 |
| 2023-03-06 | Niven Ralph (CHIEF SCIENTIFIC OFFICER) | Option Ex | 2,250 | 1.94 | 4,365 |
| 2023-03-01 | Noyes Timothy P (CHIEF EXECUTIVE OFFICER) | Sale | 15,000 | 24.22 | 363,285 |
| 2023-03-01 | Noyes Timothy P (CHIEF EXECUTIVE OFFICER) | Option Ex | 15,000 | 2.14 | 32,100 |
| 2023-02-06 | Dake Benjamin T (SEE REMARKS) | Sale | 10,284 | 24.77 | 254,734 |
| 2023-02-06 | Dake Benjamin T (SEE REMARKS) | Option Ex | 10,284 | 1.94 | 19,950 |
| 2023-02-06 | Niven Ralph (CHIEF SCIENTIFIC OFFICER) | Sale | 2,250 | 24.27 | 54,612 |
| 2023-02-06 | Niven Ralph (CHIEF SCIENTIFIC OFFICER) | Option Ex | 2,250 | 1.94 | 4,365 |
| 2023-02-01 | Noyes Timothy P (CHIEF EXECUTIVE OFFICER) | Sale | 15,000 | 22.79 | 341,790 |
| 2023-02-01 | Noyes Timothy P (CHIEF EXECUTIVE OFFICER) | Option Ex | 15,000 | 2.14 | 32,100 |
| 2023-01-06 | Dake Benjamin T (SEE REMARKS) | Sale | 10,284 | 26.29 | 270,335 |
| 2023-01-06 | Dake Benjamin T (SEE REMARKS) | Option Ex | 10,284 | 1.94 | 19,950 |
| 2023-01-05 | Niven Ralph (CHIEF SCIENTIFIC OFFICER) | Sale | 2,250 | 26.40 | 59,404 |
| 2023-01-05 | Niven Ralph (CHIEF SCIENTIFIC OFFICER) | Option Ex | 2,250 | 1.94 | 4,365 |
| 2022-12-12 | Dake Benjamin T (SEE REMARKS) | Sale | 4,118 | 28.30 | 116,542 |
| 2022-12-12 | Dake Benjamin T (SEE REMARKS) | Option Ex | 4,118 | 2.14 | 8,812 |
| 2022-12-12 | Eldridge George A (SEE REMARKS) | Sale | 10,000 | 30.04 | 300,430 |
| 2022-12-12 | Eldridge George A (SEE REMARKS) | Option Ex | 10,000 | 2.14 | 21,400 |
| 2022-12-09 | Dake Benjamin T (SEE REMARKS) | Sale | 394 | 25.03 | 9,861 |
| 2022-12-09 | Dake Benjamin T (SEE REMARKS) | Option Ex | 394 | 2.14 | 843 |
| 2022-12-09 | Eldridge George A (SEE REMARKS) | Sale | 3,969 | 24.73 | 98,165 |
| 2022-12-09 | Eldridge George A (SEE REMARKS) | Option Ex | 3,969 | 2.14 | 8,493 |
| 2022-12-08 | Dake Benjamin T (SEE REMARKS) | Sale | 10,000 | 22.30 | 223,050 |
| 2022-12-08 | Dake Benjamin T (SEE REMARKS) | Option Ex | 10,000 | 2.14 | 21,400 |
| 2022-12-08 | Eldridge George A (SEE REMARKS) | Sale | 12,011 | 21.63 | 259,845 |
| 2022-12-08 | Eldridge George A (SEE REMARKS) | Option Ex | 12,011 | 2.14 | 25,703 |
| 2022-12-07 | Eldridge George A (SEE REMARKS) | Sale | 11,637 | 19.88 | 231,390 |
| 2022-12-07 | Eldridge George A (SEE REMARKS) | Option Ex | 11,637 | 2.14 | 24,903 |
| 2022-12-06 | Dake Benjamin T (SEE REMARKS) | Sale | 40,000 | 17.15 | 686,000 |
| 2022-12-06 | Dake Benjamin T (SEE REMARKS) | Option Ex | 40,000 | 1.94 | 77,600 |
| 2022-12-01 | Noyes Timothy P (CHIEF EXECUTIVE OFFICER) | Sale | 45,000 | 18.00 | 810,000 |
| 2022-12-01 | Noyes Timothy P (CHIEF EXECUTIVE OFFICER) | Option Ex | 45,000 | 2.14 | 96,300 |
| 2022-11-30 | Eldridge George A (SEE REMARKS) | Sale | 255 | 19.06 | 4,860 |
| 2022-11-30 | Eldridge George A (SEE REMARKS) | Option Ex | 255 | 2.14 | 543 |
| 2022-11-22 | Eldridge George A (SEE REMARKS) | Sale | 174 | 19.01 | 3,308 |
| 2022-11-22 | Eldridge George A (SEE REMARKS) | Option Ex | 174 | 2.14 | 372 |
| 2022-11-21 | Eldridge George A (SEE REMARKS) | Sale | 2 | 19.00 | 38 |
| 2022-11-21 | Eldridge George A (SEE REMARKS) | Option Ex | 2 | 2.14 | 4 |
| 2022-11-18 | Eldridge George A (SEE REMARKS) | Sale | 861 | 19.79 | 17,042 |
| 2022-11-18 | Eldridge George A (SEE REMARKS) | Option Ex | 861 | 2.14 | 1,842 |
| 2022-11-11 | Dake Benjamin T (SEE REMARKS) | Sale | 6,198 | 21.33 | 132,215 |
| 2022-11-11 | Dake Benjamin T (SEE REMARKS) | Option Ex | 6,198 | 2.14 | 13,263 |
| 2022-11-10 | Dake Benjamin T (SEE REMARKS) | Sale | 1,800 | 20.10 | 36,172 |
| 2022-11-10 | Dake Benjamin T (SEE REMARKS) | Option Ex | 1,800 | 2.14 | 3,852 |
| 2022-11-09 | Dake Benjamin T (SEE REMARKS) | Sale | 14,000 | 17.91 | 250,683 |
| 2022-11-09 | Dake Benjamin T (SEE REMARKS) | Option Ex | 14,000 | 2.14 | 29,960 |
| 2022-10-18 | Dake Benjamin T (SEE REMARKS) | Sale | 5,705 | 21.08 | 120,284 |
| 2022-10-18 | Dake Benjamin T (SEE REMARKS) | Option Ex | 5,705 | 2.14 | 12,208 |
| 2022-10-17 | Dake Benjamin T (SEE REMARKS) | Sale | 4,185 | 20.16 | 84,377 |
| 2022-10-17 | Dake Benjamin T (SEE REMARKS) | Option Ex | 4,185 | 2.14 | 8,955 |
| 2022-10-14 | Dake Benjamin T (SEE REMARKS) | Sale | 110 | 20.05 | 2,205 |
| 2022-10-14 | Dake Benjamin T (SEE REMARKS) | Option Ex | 110 | 2.14 | 235 |
| 2022-10-10 | Dake Benjamin T (SEE REMARKS) | Sale | 4,954 | 17.00 | 84,232 |
| 2022-10-10 | Dake Benjamin T (SEE REMARKS) | Option Ex | 4,954 | 2.14 | 10,601 |
| 2022-10-05 | Niven Ralph (CHIEF SCIENTIFIC OFFICER) | Sale | 2,250 | 15.96 | 35,921 |
| 2022-10-05 | Niven Ralph (CHIEF SCIENTIFIC OFFICER) | Option Ex | 2,250 | 1.94 | 4,365 |
| 2022-09-09 | Dake Benjamin T (See Remarks) | Sale | 4,720 | 18.02 | 85,054 |
| 2022-09-09 | Dake Benjamin T (See Remarks) | Option Ex | 4,720 | 1.94 | 9,156 |
| 2022-09-08 | Dake Benjamin T (See Remarks) | Sale | 3,120 | 18.28 | 57,042 |
| 2022-09-08 | Dake Benjamin T (See Remarks) | Option Ex | 3,120 | 1.74 | 5,428 |
| 2022-09-07 | Dake Benjamin T (See Remarks) | Sale | 3,662 | 18.27 | 66,901 |
| 2022-09-07 | Dake Benjamin T (See Remarks) | Option Ex | 8,220 | 1.74 | 14,302 |
| 2022-09-06 | Dake Benjamin T (See Remarks) | Sale | 9,166 | 18.90 | 173,237 |
| 2022-09-06 | Dake Benjamin T (See Remarks) | Option Ex | 9,166 | 1.74 | 15,948 |
| 2022-08-16 | Dake Benjamin T (See Remarks) | Sale | 21,000 | 23.27 | 488,774 |
| 2022-08-16 | Dake Benjamin T (See Remarks) | Option Ex | 21,000 | 1.74 | 36,540 |
| 2022-08-11 | Dake Benjamin T (See Remarks) | Sale | 1,347 | 24.22 | 32,624 |
| 2022-08-11 | Dake Benjamin T (See Remarks) | Option Ex | 1,347 | 1.74 | 2,343 |
| 2022-08-10 | Dake Benjamin T (See Remarks) | Sale | 12,720 | 24.27 | 308,727 |
| 2022-08-10 | Dake Benjamin T (See Remarks) | Option Ex | 12,720 | 1.74 | 22,132 |
| 2022-08-09 | Dake Benjamin T (See Remarks) | Sale | 8,700 | 24.18 | 210,383 |
| 2022-08-09 | Dake Benjamin T (See Remarks) | Option Ex | 8,700 | 1.74 | 15,138 |
| 2022-08-08 | Dake Benjamin T (See Remarks) | Sale | 6,943 | 24.66 | 171,249 |
| 2022-08-08 | Dake Benjamin T (See Remarks) | Option Ex | 6,943 | 1.74 | 12,080 |
| 2021-07-02 | Atlas Venture Associates Xii, Llc | Buy | 535,714 | 14.00 | 7,499,996 |
| 2021-07-02 | Cormorant Private Healthcare Fund Ii, Lp | Buy | 500,000 | 14.00 | 7,000,000 |
| 2021-07-02 | Grayzel David S. | Buy | 535,714 | 14.00 | 7,499,996 |
| 2021-07-02 | Katabi Maha | Buy | 357,142 | 14.00 | 4,999,988 |
| 2021-07-02 | Shah Rajeev M. | Buy | 2,785,714 | 14.00 | 38,999,996 |
| 2021-07-02 | Healy James | Buy | 357,142 | 14.00 | 4,999,988 |
Insider trading activities including stock purchases, stock sales, and option exercises of JBIO listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Jade Biosciences, Inc. (symbol JBIO, CIK number 1798749) see the Securities and Exchange Commission (SEC) website.